Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-sensitive recurrent ovarian cancer
暂无分享,去创建一个
P. Neven | D. Lambrechts | I. Vergote | N. Concin | Sileny N. Han | A. Vanderstichele | P. Busschaert | S. Olbrecht | R. Salihi | L. Loverix | Els Van Niewenhuysen | Toon Van Gorp